Consider Steroids for Some Hospitalized COVID-19 Patients

August 2020

Questions are flooding in about whether dexamethasone is a “breakthrough” in treating COVID-19.

The buzz is from a U.K. study that suggests dexamethasone reduces mortality in hospitalized patients with severe COVID-19.

This contradicts early guidance to avoid adding steroids for COVID-19...due to lack of benefit and possible harm seen in SARS and MERS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote